Drent, Marjolein http://orcid.org/0000-0003-1586-0110
Wijnen, Petal A. http://orcid.org/0000-0001-7999-2732
Jessurun, Naomi T. http://orcid.org/0000-0002-8267-1259
Harmsze, Ankie M. http://orcid.org/0000-0002-3134-6608
Bekers, Otto http://orcid.org/0000-0003-2902-2927
Bast, Aalt http://orcid.org/0000-0002-5383-2789
Clinical trials referenced in this document:
Documents that mention this clinical trial
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
https://doi.org/10.1007/s40264-021-01105-8
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
https://doi.org/10.1007/s40264-024-01400-0
Article History
Accepted: 18 January 2024
First Online: 9 March 2024
Declarations
:
: This research received no external funding.
: Marjolein Drent, Petal A. Wijnen, Naomi T. Jessurun, Ankie M. Harmsze, Otto Bekers, and Aalt Bast have no conflicts of interest that are directly relevant to the content of this article.
: The study was conducted according to the principles of the Declaration of Helsinki (version 5, 2004) and in accordance with the Dutch Medical Research Involving Human Subjects Act (WMO). The protocol was approved by the Medical Research Ethics Committees United of St. Antonius Hospital (approval R05-08A).
: All participants provided written informed consent.
: Not applicable.
: Anonymized data can be made available to investigators upon request to the corresponding author.
: Not applicable.
: All authors read and approved the final version. Conceptualization: MD and PAW had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: MD, NTJ, PAW. Acquisition, analysis, or interpretation of data: MD, PAW, NTJ, AB. Drafting of the manuscript: MD, NTJ, PAW, AB. Critical revision of the manuscript for important intellectual content: AB, AH, OB. Statistical analysis: PAW, MD. Administrative, technical, or material support: MD, PAW. Supervision: MD.